emphysema treatment options

Emphysema Treatment Options

If you have been diagnosed with emphysema, your treatment options will probably be some of the first things you’ll discuss with your doctor. Emphysema, which is one of the prominent types of chronic obstructive pulmonary disease (COPD), will progressively make it harder to breathe. As such, the sooner you develop a treatment plan, the more effective you may be at minimizing symptoms.

The most common traditional treatment methods for emphysema include:

  • Medicated inhalers — Bronchodilators may be prescribed to relax the bronchiolar muscles and promote airflow in the lungs. Corticosteroids can also be prescribed to reduce inflammation.
  • Medication — Antibiotics are often prescribed to prevent or treat an antibacterial infection that can contribute to the symptoms of emphysema.
  • Oxygen therapy — Oxygen is typically used for those with more severe cases of emphysema. Oxygen can be used on either a full-time or supplemental basis, such as when the patient is at home or exercising, to increase blood oxygen levels.

The Lung Institute offers a viable alternative to treating emphysema: stem cell therapy. Unlike traditional medications and therapy, which generally only address the condition’s symptoms and not its underlying causes, stem cell therapy has been shown to potentially slow the progression of the disease and reduce lung inflammation. More than 80 percent of patients who have undergone treatment at the Lung Institute have reported an improvement in overall quality of life following one of our natural emphysema treatment options.

If you are interested in learning more about the natural emphysema treatment options we offer through our use of stem cell therapy, call the dedicated Lung Institute team today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.